Daye Jianfeng passed the on-site evaluation of Huangshi "Mayor Quality Award"
Release time:
2021-09-13
News from our newspaper 8# February 31 and 9# June 1 , the on-site evaluation team of the 7th Mayor Quality Award of Huangshi City, composed of leaders of Huangshi Market Supervision Bureau, Daye Market Supervision Bureau and relevant experts, conducted an on-site evaluation of Daye Peak Cement Company for a period of 2 days. The work of Daye Peak was well received by the members of the review team and passed the on-site review smoothly.
The review team conducts a comprehensive review of the management quality composed of the leadership, strategy, customers, measurement analysis and knowledge management, employees, operations, results and other elements of Daye Peak through on-site inspection and defense, consulting various materials, holding seminars and other forms in accordance with the "Huangshi Mayor Quality Award Management Measures" and its review criteria and standards. At the final meeting of the review, the expert group started from "adhering to the development of the group culture, leading the development of the enterprise", "continuous improvement and innovation, promoting the rapid development of the enterprise", "integration of industrialization and industrialization, helping the enterprise to improve efficiency and efficiency, promoting development", "brand quality, honest sales, good service, customer satisfaction, promoting development", "people-oriented, pro-strict combination", stable staff, in the six aspects of "promoting sustainable development of enterprises", "practicing environmental protection and clean and green production, actively fulfilling responsibilities, conducive to enterprise development", we affirm and highly appraise Daye peak's introduction of excellent performance management mode; and combined with the actual operation of Daye peak, starting from the sustainable development of enterprises and enterprise vision, put forward improvement suggestions for strategic planning and analysis, enterprise knowledge management and talent team construction, and from the safety, technological transformation, the development of upstream and downstream industries and other aspects of the proposal.All members of Daye Peak Management Team attended the final meeting of the review and listened carefully to the opinions and suggestions of the expert group. Zhang Fengliang, deputy general manager of the group company and general manager of Daye Peak, said that Daye Peak will continue to improve in the future operation process, give full play to its advantages, and at the same time earnestly implement the improvement suggestions put forward by the expert group, and continue to improve in the future work. Realize the sustainable development of the enterprise.
(Fan Liangwu
Chen Cuihong)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31